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Summary
Cloned allospecific cytolytic T lymphocytes (CTL) adhere to purified class I alloantigen immobilized
on plastic and degranulate in response to it. Binding and degranulation are inhibited by drugs
that impair cytoskeletal function. Cytochalasins D and E, which interfere with microfilament
function, and colchicine, which disrupts microtubules, were used and gave qualitatively similar
results. Concentrations of these drugs that inhibited degranulation in response to alloantigen
did not inhibit response to immobilized anti-T cell receptor (TCR) antibody. Neither did they
inhibit response when alloantigen was co-immobilized with an antibody against class I on the
CTL to promote adhesion between the CTL and antigen-bearing surface. Thus, neither trans-
membrane signal generation via the TCR nor degranulation per se were prevented. Instead, the
drugs act to prevent the initial adhesion to alloantigen. CTL binding to alloantigen depends
in part on CD8-class I interaction, and adhesion via CD8 is "activated" by crosslinking the
TCR with soluble antiTCR antibody. This adhesion, too, is shown to be cytoskeleton dependent.
A variety of evidence indicates that cytoskeletal elements
play important roles in T cell recognition and response
to antigen-bearing cells. It has been known for some time
that lysis of target cells by CTL is blocked by cytochalasins
(1-6), which interfere with microfilament function, and by
colchicine (4-8), which disrupts microtubules. More recently,
selective reorganization of cytoskeletal proteins has been ob-
served in both CTL and T helper cells upon interaction with
antigen-bearing cells. Talin becomes localized inside the T
cell in the region of cell-cell contact and the microtubule
organizing center, Golgi apparatus, and granules undergo polar
reorientation to the region ofcontact (9-14). Thesecytoskeletal
changes are observed only when the T cell is in contact with
a cell bearing antigen, and not when the T cell is nonspe-
cifically bound to another cell. This dependence on specific an-
tigen interaction suggests that these are triggered events, but
the functional consequences of these cytoskeletal reorganiza-
tions are not known.
Cytochalasins prevent binding of CTL to target cells to
form stable conjugates, but have little or no effect on the
subsequent events leading to target cell lysis (1-6). CTL
binding to targets is a complex process, with several CTL
surface proteins implicated as having roles in adhesion, in-
cluding the antigen-specific TCR, CD8, LFA-1/1-CAM, and
CD2/LFA3 (15, 16). To define better the role(s) ofcytoskeletal
elements in adhesion, we have examined the effects of cyto-
chalasins and colchicine on CTL interacting with purified
class I alloantigen.
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Immobilized class I alloantigen is a sufficient ligand for
binding ofcloned CTL and triggering ofthe degranulation
response (17, 18). Under conditions where class I protein is
the only available ligand, binding and response depend upon
both TCR binding to antigen and CD8 binding to nonpoly-
morphic regions of class I. Furthermore, it has been recently
shown that binding of CD8 to class I is activated via the
TCR, and that the CD8-class I interaction results in some
additional signal(s) required to trigger degranulation when
TCR crosslinking is minimal (19).
The results described in this report demonstrate that agents
that perturb cytoskeletal function prevent binding to immobi-
lizedclass I alloantigen and inhibit the degranulation response.
In contrast, binding and degranulation in response to im-
mobilized antiTCR antibody are not inhibited by these agents
in the same concentration range. Thus, neither TCRmediated
transmembrane signal generation nor degranulation per se
are inhibited. Furthermore, it is shown that inhibition ofthe
binding to alloantigen results, at least in part, from inhibi-
tion of the CD8 binding to class I that is activated via the
TCR. These results have implications for the mechanism of
TCRactivated, CD8-mediated adhesion of T cells.
Materials and Methods
Mice and Cell Lines.
￿
C57BL/6 (H-26) mice were purchased
from the Jackson Laboratory, Bar Harbor, ME. EL4 (H-26)
C57BL/6 thymoma, P815 (H-2d), a DBA/2 mastocytoma, and
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culture and passaged as ascites.
The Kb-specific clones 6, 11, and 13 were derived from perito-
neal exudate cells of (B10.BR x B10.D2)Fl (H-2k x H-2d) mice
10-13 d after priming by intraperitoneal injection with 2 x 10'
EL4 cells. Cells were stimulated in vitro under limiting dilution
conditions with irradiated B10.A(5R) (H-2bi') spleen cells and
10% rat Con A supernatants. Clones were maintained by weekly
stimulation with C57BL/6 stimulator cells and human rIIT2
(10 U/ml) in culture medium consisting of RPMI 1640 sup-
plemented with 20 mM Hepes, 2 MM. L-glutamine, (3-mercapto-
ethanol (5 x 10-5 M), penicillin-streptomycin (100,ug/ml), 1 mM
sodium pyruvate, 0.1 mM nonessential aminoacids, and 10% heat-
inactivated FCS.
Monoclonal Antibodies.
￿
The mAbs used were 11-4.1, anti-Kk
(20), M1/42, rat anti-mouse class I (21, 22), and F23.1, antiV/38
TCR (23). 11-4.1 and F23.1 antibodies were purified by affinity
chromatography usingprotein A-Sepharose andM1/42by ammo-
nium sulfate fractionation followed by DEAE-chromatography.
Purification of Class IAntigens.
￿
H-2K1 was purified from TX-
100 1ysates of EL4 (KbD') tumor cells by affinity chromatography
on an M1/42 mAbcolumn as previously described(22). TheM1/42
mAb, a rat IgG that binds most murine class I proteins, does not
bind H-2Db antigen under the conditions used for the affinity-
chromatography (24). H-2D1 was purified from TX-100 lysates of
P815 (K'Dd) tumor cells using an M1/42 mAb column as previ-
ously described(22, 24). H-2 preparations were quantitated by pro-
tein determination (25) and ELISA (24). For comparison, all H-2K6
preparations were quantitated by ELISArelative to a single H-2Kk
preparation as the standard, using M1/42 mAb as the first anti-
body (24). Purity of class I protein preparations was assessed by
SDS-PAGE, with protein visualized by staining with Coomassie
Blue.
Protein Immobilization on Plastic.
￿
Purified H-2 eluted from mAb
affinity columnswas at concentrations of 25-150 lAg/ml in 10 mM
Tris buffer containing 0.5% deoxycholate and 0.15 M NaCl. An-
tigens were stored frozen in this buffer, and no losses in either sero-
logical activity or CTL stimulating activity have been noted over
severalmonths storage. Foruse, H-2 wasdiluted directly into Dul-
becco's PBS, pH 7.4, to a concentration of 0.1-1 Fcg/ml. 0.1 ml
ofdiluted antigen wasthen incubatedfor1.5 hat 25°C in individual
flat-bottomed microtiter wells (Falcon 3912 Flexible Assay Plate;
Becton Dickinson, Oxnard, CA). After incubation for 1.5 h, the
wells were washed four timeswith RPMI containing 2% FCS to
remove unbound antigen andblockunoccupied siteson theplastic.
Characterization andquantitation ofclassIimmobilization hasbeen
described in detail (24). mAbs were immobilized in plastic wells
in the same way, with the exception that antibody preparations
did not contain detergent. When antibody was co-immobilized
with class I, a two-step procedure was used. mAb wasfirst added
to the well and incubated for 1.5 h at 25°C. Unbound antibody
was then removed and class I protein was added and allowed to
bind for 1.5 h. Wells were then washed and blocked with FCS
as above. As previously describedin detail (26), this procedureresults
in immobilization of both proteins over the concentration ranges
described here.
Assay of CTL Degranulation.
￿
Release of serine esterase (SE)'
activity in response to plate-bound proteins was determined by ad-
dition of 105 CTL/well in 0.1 ml of RPMI medium buffered with
t Abbreviations used in this paper:CD, cytochalasin D; CE, cytochalasin E;
SE, serine esterase.
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15 mM Hepes and containing 2% FCS. In cases where degranula-
tion in response to target cells was measured, 1 x 105 CTL and
2 x 105 EL4 target cells were added to wells previously blocked
by washing with 2% FCS. Plates were then briefly centrifuged
and incubated at 37°C for varying times. After incubation, plates
were againbrieflycentrifuged, 0.02-ml aliquots ofsupernatant were
removed, and SE activity was determined as previously described
(18, 27). SE substrate, N-benzyloxycarbonyl-L-lysine thiobenzyl ester
(BIT), was purchased from Calbiochem-Behring-Corp., La Jolla,
CA, and 5'5-dithiobis (2-nitrobenzoic acid) was purchased from
Sigma Chemical Co. (St. Louis, MO).
Each experiment included CTL incubated in blocked wells in
the absence of stimulus to determine the level of spontaneous SE
release. Totalcellular serine esterase activity was determined in each
experiment by extracting CTL with 0.5% NP-40 and assaying ac-
tivity in theextract (17, 26). Data arepresented as percent specific
esterase release calculated as: percent specific release = 100 x
[(E-S)/(T-S)], where E is the experimental value, S is the es-
terase activity spontaneously released by CTL in the absence of
stimulation, and T is the total esterase activity extractable with
detergent. Spontaneous release (S)was <10% of stimulated release
in allexperiments. Measurementof totalesterase activity in NP-40
extracts showed thetarget cells to have <1% of the activity present
in the CTL.
Allexperiments hadduplicateor triplicate wellsfor each condi-
tion being tested andthese values varied by <10% in allcases. For
the cloned CTLused in this study, antigen-stimulated degranula-
tion normally resultsin 25-50% of thetotalSE present in the cell
being released in 2-3 h (17-19). Longer incubation with antigen
does not result in significantly more degranulation. Allof the ex-
periments examining effects of inhibitors on degranulation were
repeated at least three times with essentially identical results, and
the data shown are representative.
CytotoxicityAssay.
￿
CTL lytic activity wasdetermined in a 4-h
"Cr-release assay. Varying numbers of effector cells were incubated
with 1 x 104 "Cr-labeled tumor cell targets in a final volume of
0.2 ml in V-bottomedwells. After4h at 37°C, 100P.1 ofthesuper-
natants were harvestedand radioactivity was determined. Sponta-
neous release (SR) from target cells was determined by incubation
in the absence of CTL, and total releasable (TR) was determined
by freeze thaw lysis. Percent specific cytotoxicity was calculated as:
percent specific cytotoxicity = 100 x [(experimental release -
SR)/(TR -SR)]. Cloned CTLused in these studies were periodi-
cally tested to insure that they retained specific cytolytic activity.
AssayofCTL Binding.
￿
CTLwere labeled by incubating in PBS
for 1 h at 37°C using 1001ACiNa"Cr04 per 10' cells. Cells were
then washed and resuspended at 106/ml in RPMI medium con-
taining 2.5% FCS. Binding was initiated by adding 105 cells per
well in 0.1 ml andcentrifuging at 1,200rpmfor 1 min. Plates were
then incubated for varying times at 37°C in a 5% COZ at-
mosphere. At theendof this time 0.1 ml of PBS was added, plates
were placed on an ice/water bath for 10 min, and unbound cells
were then removedby pipeting 10 times with aPipetman (Gilson
Co., Inc. Worthington, OH). Well bottoms were then cut off
and radioactivity was determined. Spontaneous release of "Cr was
determined forcellsincubated in parallel underidentical conditions.
Binding was calculated as percent cells bound = 100 x [(cpm
bound)/(total - spontaneous cpm)]. Visual counting confirmed
that this procedure provided an accurate measurement of bound
cells. All of the experiments examining effects of inhibitors on
bindingwere repeated at least threetimeswith essentially identical
results.
In some experiments, SE release and bindingwere examined forthe same cells. In this case, at the end of the 37°C incubation,
0.02-ml aliquots were removed from wells for esterase activity de-
termination, and the wellswere then treated as above to determine
binding. Direct comparison of unlabeled and "Cr-labeled cells
showed that degranulation in response to antigen or antiTCR an-
tibody was not affected by the "Cr labeling (data not shown).
Inhibitors ofCytoskeletalFunction.
￿
Colchicine and cytochalasins
D (CD) and E (CE) were purchased from Sigma Chemical Co.
Colchicine was dissolved directly in assay medium for use.
Cytochalasins weredissolved in DMSO at a concentration of2 mM,
and diluted into medium to the desired final concentration. Con-
trols done in all experiments included addition of DMSO to the
same final concentration present when cytochalasin was added. Over
the concentration range used (up to 1% final concentration), DMSO
had no significant effects on degranulation, binding or cytolysis.
Cytochalasins and colchicinehad no effect on measured SE activity
when they wereadded directly to theenzyme assay(datanot shown).
Thus, effects on SE release are not due to direct inhibition of the
activity of the enzyme following its release by exocytosis.
Results
Inhibition ofTarget Cell-stimulated Responses.
￿
Cytochalasins
and colchicine inhibit lysis of target cells by CTL popula-
tions (1-8) and cloned CTL lines (28). This was confirmed
to be the case for cloned, H-2Kb alloantigen-specific CTL
lines used in this study. CD inhibited lysis of EL4 tumor
targets by C11 with an ICso (concentration required for 50%
inhibition) of 3.3 AM (Fig. 1 A) and CE with an ICso of
0.25 AM (Fig. 1 B). Colchicine was also inhibitory, with an
ICso of 1 mM (data not shown). These values are in good
agreement with those previously reported for inhibition of
CTLmediated target lysis. Visual inspection confirmed that
inhibitory concentrations of these agents blocked conjugate
formation with the target cells.
Cloned CTL are stimulated by target cells to undergo de-
granulation which results in release of granular contents, in-
Figure 1.
￿
Cytochalasins inhibit target cell cytolysis and degranulation
by CTL. Clone 11 lysis of s1Cr-labeled EL4 target cells and degranula-
tion in response to EL4 targets were assayed as described in Materials and
Methods. Results are expressed as percent of the control response in the
absence of cytochalasin. Control cytolysis at an E/T of 1:1 was 52%, and
responses were compared basedon lytic units ofactivity determined from
lysis at three different E/T ratios. SE release was measured after a 3-h incu-
bation at 37°C. DMSOhad no significant effects on lytic activity or de-
granulation. Cytolysis ("); degranulation (O).
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cluding SE activity, into the medium (27). This response is
antigen-specific and dependent on the TCR, and can be easily
quantitated by measuring the released SE activity. SE release
by C11 in response to EL4 target cells was inhibited by CD
and CE with essentially the same dose responses as for target
cell lysis (Fig. 1, A and B).
Inhibition ofResponses to Immobilized Alloantigen or Anti-
TCR Antibody. Cloned CTL are also stimulated to degranu-
late up9n interaction with antiTCR antibodies (18, 29) or
affinity-purified classI alloantigen immobilized on plastic sur-
faces (18) . Immobilized F23.1 anti-TCR antibody and Kb al-
loantigen stimulated very comparable levels ofdegranulation
by C11 (Fig. 2). However, rytochalasins and colchicine had
very different effects on responses to these two stimuli. Re-
sponse to the Kb alloantigen was effectively inhibited by CD
and colchicine (Fig. 2), with ICsos in the same range as
those found for inhibition for target cell lysis. In contrast,
CD had little or no effect on the response to antiTCR at
concentrations up to 20 AM. Colchicine also had little or
no effect on the response to F23.1 at levels that effectively
inhibited response to Kb, although it did at least partially
inhibit response to F23.1 at higher concentrations (Fig. 2 B).
The ICso for inhibition by colchicine was somewhat vari-
able in different experiments; it ranged from 1 to 4 mM for
inhibition of the response to immobilized F23.1 mAb. In all
cases, however, the ICso for inhibition of response to Kb was
5-10-fold lower than for F23.1 mAb. Similarly, CE inhibited
the response to anti-TCR, but only at concentrations fivefold
higher than required to cause comparable inhibition of the
response to Kb (data not shown). In all of these experiments,
Kb was immobilized at a density that stimulates optimally
(18), and further increasing Kb density had no effect. Thus,
for both colchicine and CE, response to Kb was inhibited
in the same dose range as target cell lysis, while response to
antiTCR mAb was only partially affected and only at much
higher concentrations.
These results suggested that rytochalasins and colchicine
did not significantly affect the degranulation response per se,
v
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Figure 2.
￿
Effects of CD and colchicine on degranulation in response
to immobilized antiTCR mAb and class I alloantigen. F23.1 anti-TCR
mAb was immobilized at 1 pg/well and Kb at 0.1 14g/well, levels that
stimulate maximally, as described in Materials and Methods. SE release
by C11 was determined after incubation for 2.5 h at 37°C.244
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Figure 3 .
￿
Cytochalasins prevent de-
granulation onlywhen present early in
the response . SE release by C11 in re-
sponse to Kb immobilized at 0 .1 ug/
well was determined as described in
Materials and Methods. (A) Kinetics of
degranulation. SE release was deter-
mined after the indicated time of incu-
bation at 37°C . (B) Effect of CD on
degranulation.CD (20 IN) was added
to wells at the indicated time (time 0
= time of addition of C11 cells) . SE
release in allcases was measured 180min
after addition ofcells to the wells. (C)
CE (1 uM) was added at the indicated
time and SE release measured 180 min
after addition of cells to the wells.
Figure 4.
￿
Effects ofCD on Clone 11 morphology.
C11 cells were placed in wells that were coated with
(A and B) FCS, (C and D) F23 .1 anti-TCR mAb
immobilized at 1 jig/well or (E and F) Kb immobi-
lized at 0 .1 Wg/well . Plates were briefly centrifuged
atroom temperature to initiatecontact and incubated
60 min at37°C. Cells were then photographed using
an inverted microscope. CD (20 jAM) was added to
the cells 15 min before addition of the cells to wells
in panels B, D, and F.but rather earlier events that lead to antigen-specific activa-
tion. The time course of degranulation in response to im-
mobilized alloantigen displays a distinct lag phase of 30-60
min, during which little or no SE release is detectable. After
this, release occurs over the next 2 h (Fig. 3 A). To determine
the point at which interference with cytoskeletal function
affects response, inhibitors were added at various times and
the extent of degranulation then determined at the end of
3 h. Addition ofCD or CE to the CTL 15 min before they
are placed in contact with alloantigen results in complete in-
hibition of SE release over 3 h, and addition 15 min after
exposure to antigen still effectively inhibits subsequent re-
sponse (Fig. 3, B and C). In contrast, when cytochalasin ad-
dition is delayed until 30 or 60 min after exposure to an-
tigen, substantial response is detected at the end of the 3-h
period. Thus, addition during the latter portion of the lag
phase, at a time when degranulation is not yet detectable,
does not effectively prevent subsequent serine esterase release.
Essentially, the same results have been obtained in experi-
ments using colchicine at a concentration of 2 mM (data not
shown) . These results further support the conclusion that
intact microfilament and microtubule functions are critical
for early events leading to activation, but not for degranula-
tion per se.
Effects ofCytoskeletalPerturbants on CTL Morphology.
￿
CTL
undergo rapid flatteningand spreading when centrifuged onto
the coated surfaces of the microtiter plate wells used in these
experiments, and many cells appear motile. This occurs ir-
respective ofwhether a stimulus is present; cells on wells coated
with FCS do not appear different than those on wells having
immobilized F23.1 or Kb when examined immediately after
centrifugation. CD inhibits spreading, and the cells are
rounded in its presence. After incubation at 37°C in FCS-
coated wells, cells remain spread and many appear motile as
evidenced by the presence ofpseudopods (Fig. 4A). In con-
trast, cells on F23.1- or Kb-coated wells remain spread but
motile-appearing cells are no longer present (Fig. 4, C and
E; this is consistently and reproducibly seen, and in blinded
experiments, wells having an immobilized stimulus can be
readily distinguished on this basis). In all cases, cells in the
presence of CD retain a rounded morphology throughout
the incubation period (Fig. 4, B, D, and F).
Visual inspection of cells at varying CD concentrations
indicates that the dose response for the morphological effects
is very comparable to that for inhibition of degranulation
in response to Kb. However, the morphological effects are
clearly dissociated from inhibition of degranulation in the
case of stimulation by antiTCR antibody. With this stimulus,
CD causes the cells to remain rounded up under the same
conditions where degranulation is occurring, and flattening
and spreading are prevented over the entire time course of
the response (Fig. 4 D and data not shown). CE had essen-
tially the same effects on CTL morphology as those described
forCD. In contrast, colchicine did not prevent flattening and
spreading at concentrations which inhibited degranulation
in response to alloantigen (data not shown).
Response to Alloantigen Is not Inhibited when Additional Sur-
face Interactions Are Provided by Co-immobilized Antibody.
￿
We
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have previously shown that co-immobilizing a suboptimal
levelofalloantigen together with an antibody directed against
a surface protein on the CTL can dramatically augment the
degranulation response obtained (26). This can occur using
antibodies against any ofa variety ofCTL proteins, including
class I, Thy-1, CD8, and CD45. For all of these, the im-
mobilized antibody alone stimulates no response, but in its
presence a response is obtained at a surface density of alloan-
tigen that alone is insufficient to stimulate. It was also found
that the lag period in alloantigen-stimulated degranulation
was greatly reduced or eliminated when augmenting antibody
was present . This suggested the possibility that augmenta-
tion with co-immobilized antibody might bypass the cyto-
skeletal-dependent events that appear to be critical for response
to antigen.
It was found that degranulation in response to Kb co-
immobilized with anti-Kk mAb (specific for class I on the
C11 CTL) showed the same CD insensitivity as did the re-
sponse to immobilized anti TCR. In contrast, the response
to the same level of immobilized Kb alone was effectively in-
hibited (Fig. 5). Additional experiments confirmed the de-
creased lag period (26) and lack ofCD inhibition in response
to alloantigen augmented with co-immobilized antibody (not
shown). Thus, it appears that the TCR can effectively bind
alloantigen and signal for response in the presence of CD,
provided that cytoskeletal-dependent events are bypassed by
increasing surface interactions with an augmenting antibody.
Inhibition ofCTL Binding to Alloantigen.
￿
The results de-
scribed above strongly suggested that the inhibition of de-
granulation in response to alloantigen by cytochalasins and
colchicine resulted from a requirement for cytoskeletal func-
tion in order to obtain sufficient surface interaction and TCR
occupancy to initiate signaling for response. The avidity of
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Figure 5. Co-immobilized antibody that binds class I on the CTL
eliminates CD inhibition of the response to alloantigen. SE response by
Cll was determined after incubation for 3 h at 37°C. CD was added to
cells 15 min before adding cells to wells and initiating contact. Proteins
immobilized on wells were: F23.1 (1 Rg/ml) ("); Kb (0.2 Rg/well)
(O); 11-4.1 mAb (anti-Kk, 0.9 Wg/well) co-immobilized with Kb (0.2
,ug/well) (X). 11-4.1 and Kb were co-immobilized in a two-step proce-
dure as described in Materials and Methods. No response was obtained
withcells in wells havingjust immobilized 11-4.1 (not shown). Error bars
indicate standard deviations of triplicate samples.Figure6 .
￿
CD inhibitsCTL binding to alloantigen but not to immobi-
lized F23 .1 antiTCR mAb. SICr-labeled C11 cells were placed in wells
having the indicated immobilized protein in the absence (-) or presence
(+) ofCD at 15 pM . F23 .1 was immobilized at 1 ug/well and Kb at 0.2
pg/well. Binding was measured after a 150-min incubation at 37°C as
described in Materials and Methods. Total incorporation was 21,853
cpm/105 cells and spontaneous release after 150 min was 1,708 cpm/105
cells . CD had no effect on the level ofspontaneous release. Error bars indi-
cate standard deviations of triplicate samples .
surface interaction can be directly determined by measuring
TCRdependent CTL binding to alloantigen-bearing surfaces
by either visual counting or by using 5'Cr-labeled CTL .
Cloned CTL bind specifically to alloantigen but not to ir-
relevant class I proteins (17, 19) . Using the assay described
in Materials and Methods, 20-40% of the cells in the well
are found to bebound . This is consistent with observations
Figure 7 .
￿
CD inhibits CD8-mediatedCTL binding to class I triggered
by soluble antiTCR mAb . Wells were prepared having the indicated im-
mobilized Kb alloantigen (0.2 pg/well) or nonantigenic Dd (0 .2 Ag/well) .
Where used, soluble F23 .1 mAb was present at 0.025 ug/well and was
added to the cell suspension immediately before placing the cells into wells
and initiating contact by centrifugation . When used, CD orDMSO were
added to the cell suspension 15 min before placing the cells into wells.
DMSO was present at a final concentration of 1%, corresponding to the
level ofDMSO present when 20 /AM CD was added . After incubation
for 180 min at 37°C, aliquots were removed for determination of SE re-
lease, and cell binding in the same wells was then measured. Total 5'Cr
incorporation was 14,643 cpm/105 cells and spontaneous release was 589
cpm/105 . Spontaneous release was not significantly different in the pres-
ence ofCD or DMSO. All measurements were done for duplicate wells
and error bars indicate the range for the duplicates.
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of others that only a fraction of cells in a clonal population
form conjugates with targets (28, 30) .
In the presence ofCD, binding of C11 to Kb alloantigen
was reduced to almost background levels, while binding to
immobilized F23.1 antiTCR antibody was unaffected (Fig.
6) . "Cr labeling of CTL does not affect stimulated degran-
ulation (unpublished results) and SE release can therefore be
determined for the same cells as those assayed for binding.
In the experiment shown in Fig. 6, CD inhibited SE release
in response to Kb by 88%, but did not inhibit the response
to immobilized F23.1 mAb. Thus, neither degranulation nor
tight binding of theCTL to allogeneic class I can occurwhen
microfilament function is disrupted .
Inhibition of CD8-dependent Binding ofCTL to Class I Con-
served Determinants. Degranulation in response to alloantigen
depends on both TCR-antigen binding and CD8 binding
to nonpolymorphic class I determinants (18) . More recently,
it was shown that C138-mediated binding of CTL to class
I could only be detected after stimulation via the TCR (19) .
Thus, CTL do not bind to class I (other than the Kb alloan-
tigen)when unstimulated, but bind effectively when stimu-
lated by addition of soluble F23.1 antiTCR mAb. Further-
more, neither soluble antiTCRmAb alone nor nonantigenic
class I alone will stimulate degranulation . Degranulation does
occur, however, when CTL are treated with soluble antiTCR
and then allowed to bind to class 1 . Thus, it appears that
CD8 binding is activated via theTCR and that the resulting
CD8-class I interaction provides a signal required for response
when TCR crosslinking is minimal (19) . The levels ofbinding
and degranulation obtained in response to soluble antiTCR
plus class I are very comparable to those obtained when al-
loantigen is the stimulus (19) .
The fact that TCR-antigen binding and signaling were not
inhibited by CD when an augmenting antibody was co-
immobilized on the surface suggested that the early cyto-
skeletal-dependent events seen when alloantigen is the only
ligand might involve binding and/or signaling viaCD8 . Con-
sistent with this possibility, the kinetics of degranulation in
response to both immobilized alloantigen (Fig . 3) and to
soluble antiTCR plus immobilized irrelevant class I (data not
shown) displayed significant lag periods, while little or no
lag is seen for responses to immobilized antiTCR or to al-
loantigen co-immobilized with an augmenting antibody (26) .
CD was found to inhibit CD8-dependent binding of C11
to irrelevant class I (Fig. 7) . In the experiment shown, -22%
of the cells bound to Kb while no binding to Dd above back-
ground occurred in the absence of soluble antiTCR mAb.
In the presence of soluble antiTCR mAb 25% of the cells
bound to Dd . CD effectively inhibited this binding, while
DMSO had no effect at the same final concentration as used
for CD addition . As expected, degranulation occurred in re-
sponse to the combination of soluble antiTCR mAb and
Dd, but not to either stimulus alone. CD inhibited the de-
granulation in parallel with inhibition of binding (Fig. 7) .
Colchicine similarity inhibited binding and degranulation in
response to soluble antiTCRmAb and irrelevant class I pro-
tein in the 0.5-5mM concentration range (data not shown) .Discussion
Degranulation in response to target cells is inhibited both
by cytochalasins and by colchicine. Similarly, both inhibit de-
granulation in response to immobilized class I alloantigen,
and do so with dose responses comparable to those found
for target-stimulated responses. However, at these same con-
centrations neither cytochalasins nor colchicine effectively in-
hibited degranulation when immobilized antiTCR mAb was
used as the stimulus. This suggested that neither generation
of transmembrane signals nor granule exocytosis per se was
affected. Receptor-stimulated degranulation in other cell types
is similarly not prevented by cytochalasins, an example being
IgE receptor-mediated degranulation (31, 32).
Colchicine can significantly inhibit degranulation in re-
sponse to immobilized antiTCR mAb at high concentrations.
The Golgi apparatus, microtubule organizing center, and
granules ofCTL undergo reorientation to the region of con-
tact when CTL bind to target cells (9-14). It may be that
microtubule-dependent movement of granules is needed for
theirtranslocation to the site of fusion with the plasma mem-
brane, and that colchicine interferes with this. At low doses
(<1 mM; Fig. 2), the effective inhibition of response to al-
loantigen but lack ofinhibition ofresponse to antiTCR mAb
strongly suggest that microtubule-dependent events are also
required before initiation of degranulation when alloantigen
is the stimulus. The differential dose responses may reflect
differences in the stability of the microtubule structures in-
volved in antigen interaction versus granule exocytosis.
Inhibition ofresponse to antigen but not to antiTCR mAb
(Fig. 2) suggested, in the case ofantigen, that earlycytoskeletal
events are necessary to achieve sufficient receptor occupancy
for signaling to occur. This was further supported by experi-
ments examining the kinetics of degranulation and the time
of addition required for effective inhibition. Degranulation
in response to immobilized antiTCR mAb is linear from the
time of initial contact with the stimulus. In contrast, a dis-
tinct lag of 30-60 min occurs when antigen is the stimulus,
and during this time little or no SE release can be detected.
Addition of cytochalasins or colchicine early in the lag phase
prevents response, but addition late in the lag phase, at a time
when degranulation cannot yet be detected, fails to prevent
subsequent degranulation (Fig. 3). These results strongly sug-
gest that after initial contact with the antigen-bearing sur-
face, cytoskeletal dependent events must occur that lead to
sufficient receptor occupancy for signaling and response to
occur.
As in the case of immobilized antiTCR, a requirement
for early cytoskeletal events is also bypassed when an anti-
body directed against class I protein on the CTL is co-
immobilized on the antigen bearing surface (Fig. 5). Here
too, the lag phase is eliminated (26) and cytochalasins and
colchicine do not inhibit. The co-immobilized anti-class I
mAb might simply serve to increase surface interactions and
thus promote a higher level ofTCR occupancy. Alternatively,
antibody binding to the CTL class I protein might deliver
some additional signal. In any case, the response remains com-
pletely dependent on the presence of antigen, thus allowing
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the conclusion that cytochalasins and colchicine do not directly
interfere, at the level ofthe individual molecular interactions,
with antigen binding by the TCR.
Cytochalasins and colchicine, at least partially, block CTIT
target conjugate formation (1-7, 28). It appeared likely that
the early events involved in stimulation by antigen might re-
sult from a dependenceon cytoskeletal function for tight adhe-
sion to the antigen-bearing surface. This was confirmed by
the finding that cytochalasins and colchicine inhibited CTL
binding to alloantigen. This binding is mediated byboth TCR
antigen and CD8-class I interactions, and recent results have
shown that CD8 is "activated" to bind class I nonpolymorphic
determinants upon minimal crosslinking of the TCR (19).
Furthermore, the CD8-class I interaction provides some ad-
ditional signal(s) needed to activate degranulation. Both
cytochalasins and colchicine inhibited the TCR-triggered,
CD8-dependent binding and degranulation in the same dose
range required for inhibition of binding and response to al-
loantigen (Fig. 7).
A variety of evidence indicates that initial CTL contact
with alloantigen also results in TCR-mediated activation of
CD8, which then binds to class I (18 and unpublished data).
Only when this has occurred are the CTL tightly adhered
to the antigen-bearing surface (as defined by the binding assay
used here) and only then does the degranulation response occur.
Our results strongly suggest that the cytoskeletal dependence
for binding and response to antigen, as defined by sensitivity
to agents that interfere with microfilament and microtubule
function, results from a requirement for cytoskeletal func-
tion for CD8 binding to class I protein. Results obtained
using pharmacological agents as inhibitors must be interpreted
with some caution, as most of these can have multiple ac-
tions. Similar results using CD and CE give considerable
confidence that disruption of microfilament function is the
likely basis for their effects on binding and response. Whether
this is due to a direct involvement ofmicrofilament function
in these processes or alternatively to microfilament disrup-
tion causing changes in the intracellular environment (e.g.,
altered cyclic nucleotide levels) remains to be determined. Dis-
ruption of the cytoskeleton might interfere with generation
of the TCR-derived signal to "activate" CD8. However, we
do know that signaling via the TCR can occur, since signal
generation for triggering degranulation in response to im-
mobilized anti TCR mAb, or antigen co-immobilized with
antibody, is not inhibited by cytochalasins or colchicine.
T cells undergo cytoskeletal reorganization upon stimula-
tion (9-14), and these may be directly involved in CTL adhe-
sion to antigen bearing surfaces. In the absence of an under-
standing of the mechanism ofCD8 "activation" and binding,
one can only speculate as to how cytoskeletal function(s) might
be involved. Activated binding might involve cytoskeletal-
dependent, directed redistribution of CD8 to the region of
surface contact. This would appear unlikely, however, since
soluble anti TCR mAb would presumably not provide a polar
signal. Alternatively, activated binding might involve inter-
action of CD8 with cytoskeletal elements that could, for
example, result in formation of CD8 microclusters. C3bi
receptors form microclusters upon treatment of polymor-phonuclear leukocytes with PMA, and there is good correla-
tion between the extent of microclustering and the capacity
of the cells to bind C3bi-coated particles (33). Clustering of
receptors might enhance the avidity of interaction by lowering
the apparent off rate.
Another possibility for a role of the cytoskeleton is sug-
gested by the morphological observations that cytochalasins
prevent flattening and spreading of the CTL on the antigen-
bearing surface (Fig. 4). CTL interactions with target cells
normally involve contact between large areas of the cell sur-
faces (10) and binding might involve a process of zipping-up
the two surfaces, with CD8 and class I providing the zipper.
If so, limiting the area of surface contact by interfering with
cytoskeletal-dependent deformation of the cell might result
in formation oftoo few CD8-class I bonds to yieldhigh avidity
binding or adequate signal generation for a response. A re-
quirement for highly multivalent interaction over a large sur-
face area is supported by the findings that effective CTL in-
teraction with alloantigen on artificial membranes critically
depends on (a) the alloantigen surface density being in the
range of that found on normal cells, a requirement that results
primary from the density dependence for effective CD8-class
I interaction (18 and Kane, K.P., A.M. O'Rourke, and M.F.
References
2.
3.
4.
5.
6 .
Mescher, manuscript in preparation), and on (b) the size of
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the only ligand on the antigen-bearing surface. It is therefore
very likely to contribute to the cytoskeletal dependence of
CTL interaction with targets, but it may not be the only
component of this more complex set of surface interactions
that depends on cytoskeletal function. Several observations
suggest that LFA1 binding to its ligand(s) may be another.
A variety of evidence indicates that LFA-1 binding to ligands
on the target cell can make an important contribution to CTIJ
target conjugate formation (15, 16). Furthermore, Dustin and
Springer (35) and van Kooyk et al. (36) have recently presented
evidence that LFA1-mediated binding of T cells is activated
via the TCR. Finally, LFA1-mediated cell-cell interactions
are induced by PMA treatment in many cell types, and these
interactions are sensitive to inhibition by cytochalasins (15,
37, 38). It therefore appears likely that both CD8/class I and
LFA-1/I-CAM interactions represent TCR-activated, cyto-
skeletal-dependent adhesion systems important in CTL lysis
of target cells.
We thank Joy Rogers and Paul Champoux for excellent technical assistance.
These studies were supported by National Institutesof Health grant AI-26950 (M. F. Mescher), National
Science Foundation grant DCB-8409084 (E. Martz), and American Cancer Society, Inc. grant IM-415
(M. F. Mescher) K. P. Kane was supported by an American Cancer Society, Inc. Postdoctoral Fellowship.
Address correspondence to Dr. Matthew F. Mescher, Medical Biology Institute, Division of Membrane
Biology, 11077 North Torrey Pines Road, La Jolla, CA 92037.
E. Martz's permanent address is Department of Microbiology and Program in Molecular and Cell Biology,
University of Massachusetts, Amherst, MA.
Received for publication 8 June 1990 and in revised form 9 October 1990.
Cerottini, J.-C., and KT Brunner. 1972. Reversible inhibi-
tion of lymphocyte-mediated cytotoxicity by cytochalasin B.
Nature (Lon4 237:272.
Thorn, R.M., and C.S. Henney. 1976. Enumeration of specific
cytotoxic T cells. Nature (Lond.). 262:75.
Golstein, P., C. Foa, and I.C.M. MacLennan. 1978. Mecha-
nism of T cell mediated cytolysis: the differential impact of
cytochalasins at the recognition and lethal hit stages. Eur. J.
Immunol. 8:302.
Berke, G. 1980. Interaction of cytotoxic T lymphocytes and
target cells. Prog. Allergy. 27:69.
Green, W.R., and C.S. Henney. 1981. The mechanism of T
cell-mediated cytolysis. CRC Crit. Rev. Immunol. 1:259.
Martz, E . 1977. Mechanism of specific tumor cell lysis by al-
loimmune Tlymphocytes: resolution and characterization of
discrete steps in the cellular interaction . Contemp. Top Im-
munobiol. 7:301.
248
7.
8.
9.
Cytoskeletal Function in Cytotoxic T Lymphocyte Binding
Plaut, M., L.M. Lichtenstein, and C.S. Henney. 1973. Studies
on the mechanismsoflymphocyte mediated cytolysis. III. The
role ofmicrofilaments and microtubules.J. Immunol. 110:771.
Strom, T.B., M.R. Garovoy, C.B. Carpenter, and J.P. Merrill.
1973. Microtubule function in immune and non-immune lym-
phocyte mediated cytotoxicity. Science (Wash. DC). 181:171.
Bykovskaja, S.N., A.N. Rytenko, M.O. Rauschenbach, and
A.F. Bykovsky. 1978. Ultrastructural alteration ofcytolysic T
lymphocytes following their interaction with target cells. II.
Morphogenesis of secretory granules and intracellular vacuoles.
Cell. Immunol. 40:175.
Geiger, G., D. Rajen, and G. Berke. 1982. Spatial relation-
ships of microtubule organizing centers and the contact area
ofcytotoxic T lymphocytes and target cells.J. CellBiol. 95:137.
Zagury, D. 1982. Direct analysis of individual killer T cells:
susceptibility oftarget cells to lysis and secretion of hydrolytic
enzymes by CTL. Adv. Exp. Med. Biol. 146:149.12. Kupfer, A., and G. Dennert. 1984. Reorientation of the
microtubule-organizing center and the Golgi apparatus in
cloned rytotoxic T lymphocytes triggered by binding to lys-
able target cells. J. Immunol. 133:2762.
13 . Kupfer, A., S.J. Singer, and G.Dennert. 1986. On the mecha-
nism of unidirectional killing in mixtures of two rytotoxic T
lymphocytes. Unidirectional polarization of cytoplasmic or
ganelles and the membrane-associated cytoskeleton in the
effector cell. J Exp Med. 163:489.
14. Kupfer, A., and S.J. Singer. 1989. Cell biology of rytotoxic
and helper T cell functions. Annu. Rev. Immunol. 7:309.
15 . Martz, E. 1987. LFA-1 and other accessory molecules func-
tioningin adhesions of Tand B lymphocytes. Hum. Immunol.
18:3.
16 . Bierer, RE., andS.J. Burakoff. Tcell adhesion molecules. 1988.
FASEB (Fed. Am. Soc. Exp Biol.)J 10:2584.
17. Kane, K.P., S.A.N. Goldstein, and M.F. Mescher. 1988. Class
I alloantigen is sufficient for cytolytic T lymphocyte binding
and transmembrane signaling. Eur. J. Immunol. 18 :1925.
18 . Kane, K.P, L.A. Sherman, and M.F. Mescher. 1989. Molec-
ular interactions required for triggering alloantigen-specific
cytolytic T lymphocytes. J. Immunol. 142:4153.
19. O'Rourke, A.M., J. Rogers, and M.F. Mescher. 1990. CD8
binding to classIis activatedviatheTcell receptor andresults
in signaling for response. Nature (Lon4 346:187.
20. Oi, VT, P.P. Jones, J.W. Goding, L.A. Herzenberg, andL.A.
Herzenberg. 1978. Curr. Top Microbiol. Immunol. F. Melchers,
M. Potter, and N.L. Warner, editors. 81:115.
21 . Springer, IA. 1980. Cell surface differentiation in the mouse.
Characterization of `jumping' and `lineage' antigens using
xenogeneic rat monoclonal antibodies. In Monoclonal Anti
bodies. R.H. Kennett, T.J. McKeam, andK.B. Bechtol, editors.
Plenum Press, New York.
22 . Stallcup, KT, T Springer, and M.F. Mescher. 1981. Charac-
terization of an anti-H-2 monoclonal antibody andits use in
large scale antigen purification.J Immunol. 127:923.
23. Staerz, U.D., H.-G. Rammensee, J.D. Benedetto, and M.J.
Bevan. 1985. Characterization of a murine monoclonal anti-
body specific for an allotypic determinant on T cell antigen
receptor. J. Immunol. 134:3994.
24 . Kane, K.P, P. Champoux, and M.F. Mescher. 1989. Solid-
phase binding of class I and II MHC proteins: immunoassay
and T cell recognition. Mol. Immunol. 26:759.
25. Lowry O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall.
1951. Protein measurement with the Folin phenol reagent. J.
Biol. Chem. 193:265.
249
￿
O'Rourke et al.
26. Kane, K.P., and M.F. Mescher. 1990. Antigen recognition by
T cells: quantitative effects of augmentation by antibodies
providing accessory interactions.J. Immunol. 144:824.
27. Pasternak, M., and H.N. Eisen. 1985. A novel serine esterase
expressedby rytotoxic Tlymphocytes. Nature(Loud.). 314:743.
28. Perez, P,J.A. Bluestone, D.A. Stephany, andam. Segal. 1985.
Quantitative measurements of the specificity and kinetics of
conjugate formationbetweencloned rytotoxicTlymphocytes
and splenic target cells by dual parameter flow cytometry.J.
Immunol. 134:478.
29. Takayama, H., G. Trenn, WHumphrey,J.A. Bluestone, P.A.
Henkart, andM.Sitkovsky. 1987. Antigen receptor-triggered
secretion of a trypsin-type esterase from rytotoxicT lympho-
cytes. J. Immunol. 138:566.
30. Bonavida, B., TP. Bradley, andE.A. Grimm. 1983. The single-
cell assayin cell-mediated cytotoxicity. Immunol. Today. 4:196.
31 . Menon, A.K., D. Holowka, WW. Webb, and B. Baird. 1985.
Cross-linking ofreceptor-bound IgE to aggregates larger than
dimers leads to rapid immobilization.J Cell Biol. 102:541.
32. Oliver,J.M., J.C. Seagrave,R.F. Stump, J.R. Pfeiffer, andG.G.
Deanin. 1988. Signal transduction and cellular responses in
RBL2H3 mast cells. Prog. Allergy. 42:185.
33 . Detmers, PA., S.D. Wright, E. Olsen, B. Kimball, andZ.A.
Cohn. 1987. Aggregation ofcomplement receptorson human
neutrophils in the absence of ligand. J. Cell Biol. 105:1137.
34. Goldstein, S.A.N., and M.F. Mescher. 1986. Cell-sized, sup-
ported artificial membranes (pseudocytes): response ofprecursor
rytotoxic T lymphocytes to class IMHCproteins. J. Immunol.
137:3383.
35 . Dustin, M.L ., and TA. Springer. 1989. Tcell receptor cross-
linking transiently stimulates adhesiveness throughLFA-1. Na-
ture (Loud.). 341:619.
36 . van Kooyk, Y, P. van de Wiel-van Kemenade, P. Weder, T.W.
Kuijpers, andC.G. Figdor. 1989. EnhancementofLFA1 medi-
ated cell adhesion by triggering through CD2 or CD3 on T
lymphocytes. Nature (Lond.). 342:811.
37. Patarroyo, M., M. Jondal, J. Gordon, andB. Klein. 1983. Char-
acterization of the phorbol 12,13-dibutyrate (P(Bu)2) induced
bindingbetweenhuman lymphocytes. Cell. Immunol. 81:373.
38 . Rothlein, R., and TA. Springer. 1986. The requirement for
lymphocyte function-associated antigen 1 in homotypic leu-
kocyte adhesion stimulated by phorbol ester. J Exp. Med.
163:1132.